Outcomes in Patients With Postchemotherapy Residual Nonretroperitoneal Disease in Nonseminomatous Germ Cell Tumors
dc.contributor.author | King, Jennifer | |
dc.contributor.author | Ashkar, Ryan | |
dc.contributor.author | Kesler, Kenneth | |
dc.contributor.author | Althouse, Sandra K. | |
dc.contributor.author | Hanna, Nasser H. | |
dc.contributor.author | Einhorn, Lawrence H. | |
dc.contributor.author | Adra, Nabil | |
dc.contributor.department | Medicine, School of Medicine | |
dc.date.accessioned | 2024-12-09T09:15:21Z | |
dc.date.available | 2024-12-09T09:15:21Z | |
dc.date.issued | 2024 | |
dc.description.abstract | This case-control study assesses the association between teratoma in the primary tumor or postchemotherapy resections and survival outcomes. | |
dc.identifier.citation | King J, Ashkar R, Kesler K, et al. Outcomes in Patients With Postchemotherapy Residual Nonretroperitoneal Disease in Nonseminomatous Germ Cell Tumors. JAMA Oncol. 2024;10(1):132-134. doi:10.1001/jamaoncol.2023.4949 | |
dc.identifier.uri | https://hdl.handle.net/1805/44816 | |
dc.language.iso | en_US | |
dc.publisher | American Medical Association | |
dc.relation.isversionof | 10.1001/jamaoncol.2023.4949 | |
dc.relation.journal | JAMA Oncology | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Testicular neoplasms | |
dc.subject | Lymph node excision | |
dc.subject | Residual neoplasm | |
dc.title | Outcomes in Patients With Postchemotherapy Residual Nonretroperitoneal Disease in Nonseminomatous Germ Cell Tumors | |
dc.type | Article | |
ul.alternative.fulltext | https://pmc.ncbi.nlm.nih.gov/articles/PMC10636653/ |